UNSPSC 51151543: Neostigmine bromide

This classification denotes an acetylcholinesterase inhibitor with the molecular formula C12H19N2O2.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 005SYP50G5, chemically known as carbamic acid, dimethyl-, ester with (m-hydroxyphenyl)trimethylammonium bromide but more generally known as neostigmine bromide, which bears US NIH Compound Identifier 8246. European Medicines Agency schedules Neostigmine bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09195MIG.

UNSPSC 51151543 Neostigmine bromide is a Commodity code that covers pharmaceutical active ingredients and finished pharmaceutical products procured by state and local health agencies. The recent opportunities tagged to this code show state and local governments acquiring naloxone and drug deactivation systems for community health and emergency response programs, though the sourced opportunities reflect broader pharmaceutical procurement and pharmacy benefit administration rather than neostigmine specifically. Issuing bodies soliciting under this code include county health departments and state health and human services agencies; Seminole County, Florida and the Texas Health and Human Services Commission are the named recent buyers in the available record.

Activity is concentrated in Florida and Texas based on the recent opportunities. Seminole County posted an Invitation for Bid (IFB) on June 30, 2026 (response deadline July 26, 2023) for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission issued a Request for Information on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information about direct contracting capacity and value-based pharmaceutical fulfillment outside traditional pharmacy benefit manager arrangements. Neither opportunity specifies set-aside designations. The Seminole County bid includes E-Verify compliance, drug-free workplace certification, and workers' compensation and liability insurance requirements, with potential FEMA funding and associated federal compliance obligations.